Hands In Hands Recovery Center Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3521 Lomita Blvd, Torrence, CA 90505 Phone: 310-634-6354 Fax: 424-214-1190 |
Hands In Hands Consulting Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3521 Lomita Blvd., Torrence, CA 90505 Phone: 301-634-6354 Fax: 424-214-1190 |
News Archive
Elizabeth Mueller, MD, MS, has been named a 2014 Christina Manthos Mentoring Award recipient by the Society of Women in Urology (SWIU). Dr. Mueller is the division director and the fellowship program director of Female Pelvic Medicine & Reconstructive Surgery at Loyola University Health System.
Scientists involved in the EU-funded project ChildInnovac are about to publish in the online journal Plos One the results of their first clinical trial of a new nasal vaccine.
Global concerns about Zika virus aren't stopping Americans from making international travel plans, a new study finds, but many who do plan to go abroad say they want more information about the virus.
African-American women are equally, if not more, likely to experience infertility than their white counterparts, but they often cope with this traumatic issue in silence and isolation, according to a new University of Michigan study.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
› Verified 1 days ago